JRSS.US JRSIS Health Care Corporation
- Market cap
- USD 1.21M
- P/E
- -
- P/B
- 10.97x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is JRSS.US undervalued?
Graham numberThe Graham number of JRSIS Health Care Corporation cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
JRSIS Health Care Corporation fundamental analysis
No fundamental analysis for JRSIS Health Care Corporation yet.
JRSIS Health Care Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About JRSIS Health Care Corporation
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch…
Full company profileJRSIS Health Care Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
JRSIS Health Care Corporation annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 18.1M | 24.1M | 28.4M | 31.5M | 35.7M | 44.4M | 89.2K | 3.46M | 1.32M | 320K | 226K |
| Gross Profit | 11.5M | 14.2M | 16.2M | 19.0M | 20.6M | 24.2M | -14.6M | 483K | 274K | 56.1K | 34.7K |
| Operating Income | 5.02M | 6.66M | 5.99M | 4.67M | 5.59M | 4.10M | -326K | -189K | -486K | 8.17K | -10.3K |
| EBITDA | 7.49M | 9.25M | 8.51M | 5.25M | 9.03M | 4.10M | -307K | 28.8K | -450K | 20.6K | -5.64K |
| Net Income | 3.47M | 4.65M | 1.99M | 888K | 2.68M | 2.23M | -33.7M | -80.9K | -510K | 8.82K | -9.68K |
| EPS | 0.21 | 0.27 | 0.13 | 0.05 | 0.15 | 0.12 | -0.55 | 0.00 | -0.01 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 31.7M | 48.7M | 52.5M | 51.6M | 58.8M | 75.7M | 856K | 2.14M | 1.23M | 432K | 309K |
| Total Liabilities | 20.0M | 28.4M | 30.4M | 28.6M | 30.0M | 42.6M | 44.7K | 2.31M | 1.47M | 654K | 445K |
| Shareholders' Equity | 6.63M | 12.9M | 14.1M | 14.8M | 19.0M | 22.1M | 811K | -137K | -198K | -189K | -104K |
| Cash & Short-term Investments | 891K | 884K | 256K | 1.97M | 845K | 856K | 58.6K | 118K | 109K | 30.1K | 41.9K |
| Total Debt | 19.1M | 28.4M | 24.9M | 19.7M | 18.5M | 24.3M | 18.1K | 1.03M | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 4.99M | 8.34M | 9.20M | 11.8M | 10.6M | 8.23M | 3.07M | 517K | -438K | -136K | -111K |
| Capital Expenditure | 3.61M | 13.5M | 5.97M | 3.96M | 8.27M | 5.50M | 44.6K | 1.48K | 3.00 | 1.00 | 8.00 |
| Free Cash Flow | 1.38M | -5.15M | 3.23M | 7.88M | 2.37M | 2.73M | 3.02M | 515K | -438K | -136K | -111K |
| Ratios | |||||||||||
| ROE | 52.3% | 36.0% | 14.1% | 6.0% | 14.1% | 10.1% | -4,156.4% | - | - | - | - |
| ROA | 11.0% | 9.5% | 3.8% | 1.7% | 4.6% | 2.9% | -3,939.5% | -3.8% | -41.4% | 2.0% | -3.1% |
| Net Profit Margin | 19.2% | 19.2% | 7.0% | 2.8% | 7.5% | 5.0% | -37,818.6% | -2.3% | -38.5% | 2.8% | -4.3% |
| Debt to Equity | 2.88x | 2.21x | 1.76x | 1.33x | 0.97x | 1.10x | 0.02x | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
JRSIS Health Care Corporation dividends
JRSIS Health Care Corporation has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Jun 30, 2023.
Who owns JRSIS Health Care Corporation
- Insiders 96.30%
- Institutions 0.00%
- Public & others 3.70%
- Shares outstanding 93.0M
- Free float 3.13M
JRSIS Health Care Corporation company profile
- Company name
- JRSIS Health Care Corporation
- Ticker
- JRSS.US
- Exchange
- USA Stocks
- Sector
- Consumer Cyclical
- Industry
- Health Care Providers & Services
- Employees
- 36
- Fiscal year end
- December
- Address
- Bldg 2, Youth Innovation & Entrepreneurship Park, Yongzhou, China, 425000
- Phone
- 86 760 8896 3658
- Website
- jhcc.cn
About JRSIS Health Care Corporation
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was incorporated in 2013 and is based in Yongzhou, the People's Republic of China.
JRSIS Health Care Corporation management
2- Mr. Linhai ZhuCEO, CFO, President & Chairman · born 1976
- Mr. Zhuowei ZhongSecretary & Director · born 1973